Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Tax Provisions (2020 - 2025)

Historic Tax Provisions for Puma Biotechnology (PBYI) over the last 6 years, with Q3 2025 value amounting to $399000.0.

  • Puma Biotechnology's Tax Provisions rose 3711.34% to $399000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 2912.28%. This contributed to the annual value of $897000.0 for FY2024, which is 1717.45% down from last year.
  • Latest data reveals that Puma Biotechnology reported Tax Provisions of $399000.0 as of Q3 2025, which was up 3711.34% from $310000.0 recorded in Q2 2025.
  • Puma Biotechnology's 5-year Tax Provisions high stood at $536000.0 for Q4 2023, and its period low was $8000.0 during Q4 2024.
  • Its 5-year average for Tax Provisions is $198000.0, with a median of $212000.0 in 2021.
  • As far as peak fluctuations go, Puma Biotechnology's Tax Provisions soared by 29729.73% in 2023, and later crashed by 9850.75% in 2024.
  • Quarter analysis of 5 years shows Puma Biotechnology's Tax Provisions stood at $212000.0 in 2021, then soared by 38.68% to $294000.0 in 2022, then skyrocketed by 82.31% to $536000.0 in 2023, then tumbled by 98.51% to $8000.0 in 2024, then skyrocketed by 4887.5% to $399000.0 in 2025.
  • Its Tax Provisions was $399000.0 in Q3 2025, compared to $310000.0 in Q2 2025 and $293000.0 in Q1 2025.